Baillie Gifford - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,362,292
+6.0%
316,629
-4.2%
0.01%
+8.3%
Q2 2023$13,554,096
+14.0%
330,346
-0.7%
0.01%
+9.1%
Q1 2023$11,889,232
-5.7%
332,659
-0.3%
0.01%
-15.4%
Q4 2022$12,607,173
-12.3%
333,788
+2.8%
0.01%
-13.3%
Q3 2022$14,368,000
+24.8%
324,842
+4.4%
0.02%
+25.0%
Q2 2022$11,514,000
-10.9%
311,015
-10.8%
0.01%
+33.3%
Q1 2022$12,922,000
+34.5%
348,863
+10.5%
0.01%
+80.0%
Q4 2021$9,611,000
-5.1%
315,820
+4.6%
0.01%0.0%
Q3 2021$10,129,000
-6.4%
302,003
+11.3%
0.01%0.0%
Q2 2021$10,826,000
+1.2%
271,396
+14.1%
0.01%
-16.7%
Q1 2021$10,699,000
+49.9%
237,959
+88.5%
0.01%
+50.0%
Q4 2020$7,136,000
-96.9%
126,218
-97.4%
0.00%
-97.5%
Q3 2020$233,493,000
-51.8%
4,920,843
-40.1%
0.16%
-56.4%
Q2 2020$484,575,000
+17.2%
8,218,699
-6.0%
0.37%
-17.6%
Q1 2020$413,496,000
-22.1%
8,745,683
-0.5%
0.45%
-12.7%
Q4 2019$531,006,000
+5.3%
8,790,025
+4.5%
0.51%
-10.5%
Q3 2019$504,160,000
-7.1%
8,415,289
-0.3%
0.57%
-0.5%
Q2 2019$542,712,000
-22.7%
8,444,249
-2.3%
0.58%
-25.0%
Q1 2019$701,663,000
+48.3%
8,644,351
-1.2%
0.77%
+25.1%
Q4 2018$473,026,000
+2.4%
8,750,014
-2.3%
0.61%
+23.0%
Q3 2018$462,060,000
+19.5%
8,958,113
-3.5%
0.50%
+19.7%
Q2 2018$386,687,000
+40.1%
9,279,730
+48.2%
0.42%
+28.7%
Q1 2018$276,057,000
-17.0%
6,262,651
-5.3%
0.32%
-21.7%
Q4 2017$332,599,000
-5.9%
6,612,301
-5.1%
0.41%
-7.4%
Q3 2017$353,285,000
-6.8%
6,968,149
-6.4%
0.45%
-12.4%
Q2 2017$378,900,000
+20.6%
7,448,380
-4.7%
0.51%
+11.6%
Q1 2017$314,155,000
-21.9%
7,814,797
-7.1%
0.46%
-31.0%
Q4 2016$402,498,000
+29.6%
8,415,156
-0.7%
0.66%
+36.2%
Q3 2016$310,536,000
+53.9%
8,475,347
-2.2%
0.49%
+35.0%
Q2 2016$201,778,000
-39.9%
8,663,711
+4.6%
0.36%
-39.0%
Q1 2016$335,492,000
-32.9%
8,283,738
+2.5%
0.59%
-32.2%
Q4 2015$500,302,0008,078,5180.87%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
BB BIOTECH AG 6,913,172$330,657,00012.25%
TANAKA CAPITAL MANAGEMENT INC 84,953$4,063,0009.51%
Sicart Associates LLC 280,315$13,407,0009.26%
DOWLING & YAHNKE LLC 675,843$32,326,0003.62%
Opus Point Partners Management, LLC 77,550$3,709,0002.96%
Motley Fool Asset Management LLC 259,000$12,388,0002.75%
Motley Fool Wealth Management, LLC 333,604$15,956,0001.70%
ALTRINSIC GLOBAL ADVISORS LLC 921,174$44,060,0001.63%
PINNACLE ASSOCIATES LTD 1,572,045$75,191,0001.52%
Sonora Investment Management, LLC 121,703$5,821,054,0001.20%
View complete list of IONIS PHARMACEUTICALS INC shareholders